Cargando…

The burden of diabetes and hyperglycemia in Brazil-past and present: findings from the Global Burden of Disease Study 2015

BACKGROUND: Diabetes, hyperglycemia, and their complications are a growing problem in Brazil. However, no comprehensive picture of this disease burden has yet been presented to date. METHODS: We used Global Burden of Disease 2015 data to characterize diabetes prevalence, incidence and risk factors f...

Descripción completa

Detalles Bibliográficos
Autores principales: Duncan, Bruce Bartholow, Schmidt, Maria Inês, Ewerton Cousin, Moradi-Lakeh, Maziar, Passos, Valéria Maria de Azeredo, França, Elisabeth Barboza, Marinho, Fátima, Mokdad, Ali H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348777/
https://www.ncbi.nlm.nih.gov/pubmed/28293304
http://dx.doi.org/10.1186/s13098-017-0216-2
_version_ 1782514319798304768
author Duncan, Bruce Bartholow
Schmidt, Maria Inês
Ewerton Cousin
Moradi-Lakeh, Maziar
Passos, Valéria Maria de Azeredo
França, Elisabeth Barboza
Marinho, Fátima
Mokdad, Ali H.
author_facet Duncan, Bruce Bartholow
Schmidt, Maria Inês
Ewerton Cousin
Moradi-Lakeh, Maziar
Passos, Valéria Maria de Azeredo
França, Elisabeth Barboza
Marinho, Fátima
Mokdad, Ali H.
author_sort Duncan, Bruce Bartholow
collection PubMed
description BACKGROUND: Diabetes, hyperglycemia, and their complications are a growing problem in Brazil. However, no comprehensive picture of this disease burden has yet been presented to date. METHODS: We used Global Burden of Disease 2015 data to characterize diabetes prevalence, incidence and risk factors from 1990 to 2015 in Brazil. Additionally, we provide mortality, years of life lost prematurely (YLL), years of life lived with disability (YLD) and disability-adjusted life years (DALYs) lost due to diabetes, as well as similar data for chronic kidney disease (CKD) due to diabetes and, as an overall summary measure, for hyperglycemia, the latter expressed as high fasting plasma glucose (HFPG). RESULTS: From 1990 to 2015 diabetes prevalence rose from around 3.6 to 6.1%, and YLLs, YLDs, and DALYs attributable to diabetes increased steadily. The crude diabetes death rate increased 90% while that of CKD due to diabetes more than doubled. In 2015, HFPG became Brazil’s 4th leading cause of disability, responsible for 65% of CKD, for 7.0% of all disability and for the staggering annual loss of 4,049,510 DALYs. Diabetes DALYs increased by 118.6% during the period, increasing 42% due to growth in Brazil´s population, 72.1% due to population ageing, and 4.6% due to the change in the underlying, age-standardized rate of DALY due to diabetes. Main risk factors for diabetes were high body mass index; a series of dietary factors, most notably low intake of whole grains and of nuts and seeds, and high intake of processed meats; low physical activity and tobacco use, in that order. CONCLUSIONS: Our study demonstrates that diabetes, CKD due to diabetes, and hyperglycemia produce a large and increasing burden in Brazil. These findings call for renewed efforts to control the joint epidemics of obesity and diabetes, and to develop strategies to deal with the ever-increasing burden resulting from these diseases. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13098-017-0216-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5348777
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53487772017-03-14 The burden of diabetes and hyperglycemia in Brazil-past and present: findings from the Global Burden of Disease Study 2015 Duncan, Bruce Bartholow Schmidt, Maria Inês Ewerton Cousin Moradi-Lakeh, Maziar Passos, Valéria Maria de Azeredo França, Elisabeth Barboza Marinho, Fátima Mokdad, Ali H. Diabetol Metab Syndr Research BACKGROUND: Diabetes, hyperglycemia, and their complications are a growing problem in Brazil. However, no comprehensive picture of this disease burden has yet been presented to date. METHODS: We used Global Burden of Disease 2015 data to characterize diabetes prevalence, incidence and risk factors from 1990 to 2015 in Brazil. Additionally, we provide mortality, years of life lost prematurely (YLL), years of life lived with disability (YLD) and disability-adjusted life years (DALYs) lost due to diabetes, as well as similar data for chronic kidney disease (CKD) due to diabetes and, as an overall summary measure, for hyperglycemia, the latter expressed as high fasting plasma glucose (HFPG). RESULTS: From 1990 to 2015 diabetes prevalence rose from around 3.6 to 6.1%, and YLLs, YLDs, and DALYs attributable to diabetes increased steadily. The crude diabetes death rate increased 90% while that of CKD due to diabetes more than doubled. In 2015, HFPG became Brazil’s 4th leading cause of disability, responsible for 65% of CKD, for 7.0% of all disability and for the staggering annual loss of 4,049,510 DALYs. Diabetes DALYs increased by 118.6% during the period, increasing 42% due to growth in Brazil´s population, 72.1% due to population ageing, and 4.6% due to the change in the underlying, age-standardized rate of DALY due to diabetes. Main risk factors for diabetes were high body mass index; a series of dietary factors, most notably low intake of whole grains and of nuts and seeds, and high intake of processed meats; low physical activity and tobacco use, in that order. CONCLUSIONS: Our study demonstrates that diabetes, CKD due to diabetes, and hyperglycemia produce a large and increasing burden in Brazil. These findings call for renewed efforts to control the joint epidemics of obesity and diabetes, and to develop strategies to deal with the ever-increasing burden resulting from these diseases. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13098-017-0216-2) contains supplementary material, which is available to authorized users. BioMed Central 2017-03-14 /pmc/articles/PMC5348777/ /pubmed/28293304 http://dx.doi.org/10.1186/s13098-017-0216-2 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Duncan, Bruce Bartholow
Schmidt, Maria Inês
Ewerton Cousin
Moradi-Lakeh, Maziar
Passos, Valéria Maria de Azeredo
França, Elisabeth Barboza
Marinho, Fátima
Mokdad, Ali H.
The burden of diabetes and hyperglycemia in Brazil-past and present: findings from the Global Burden of Disease Study 2015
title The burden of diabetes and hyperglycemia in Brazil-past and present: findings from the Global Burden of Disease Study 2015
title_full The burden of diabetes and hyperglycemia in Brazil-past and present: findings from the Global Burden of Disease Study 2015
title_fullStr The burden of diabetes and hyperglycemia in Brazil-past and present: findings from the Global Burden of Disease Study 2015
title_full_unstemmed The burden of diabetes and hyperglycemia in Brazil-past and present: findings from the Global Burden of Disease Study 2015
title_short The burden of diabetes and hyperglycemia in Brazil-past and present: findings from the Global Burden of Disease Study 2015
title_sort burden of diabetes and hyperglycemia in brazil-past and present: findings from the global burden of disease study 2015
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348777/
https://www.ncbi.nlm.nih.gov/pubmed/28293304
http://dx.doi.org/10.1186/s13098-017-0216-2
work_keys_str_mv AT duncanbrucebartholow theburdenofdiabetesandhyperglycemiainbrazilpastandpresentfindingsfromtheglobalburdenofdiseasestudy2015
AT schmidtmariaines theburdenofdiabetesandhyperglycemiainbrazilpastandpresentfindingsfromtheglobalburdenofdiseasestudy2015
AT ewertoncousin theburdenofdiabetesandhyperglycemiainbrazilpastandpresentfindingsfromtheglobalburdenofdiseasestudy2015
AT moradilakehmaziar theburdenofdiabetesandhyperglycemiainbrazilpastandpresentfindingsfromtheglobalburdenofdiseasestudy2015
AT passosvaleriamariadeazeredo theburdenofdiabetesandhyperglycemiainbrazilpastandpresentfindingsfromtheglobalburdenofdiseasestudy2015
AT francaelisabethbarboza theburdenofdiabetesandhyperglycemiainbrazilpastandpresentfindingsfromtheglobalburdenofdiseasestudy2015
AT marinhofatima theburdenofdiabetesandhyperglycemiainbrazilpastandpresentfindingsfromtheglobalburdenofdiseasestudy2015
AT mokdadalih theburdenofdiabetesandhyperglycemiainbrazilpastandpresentfindingsfromtheglobalburdenofdiseasestudy2015
AT duncanbrucebartholow burdenofdiabetesandhyperglycemiainbrazilpastandpresentfindingsfromtheglobalburdenofdiseasestudy2015
AT schmidtmariaines burdenofdiabetesandhyperglycemiainbrazilpastandpresentfindingsfromtheglobalburdenofdiseasestudy2015
AT ewertoncousin burdenofdiabetesandhyperglycemiainbrazilpastandpresentfindingsfromtheglobalburdenofdiseasestudy2015
AT moradilakehmaziar burdenofdiabetesandhyperglycemiainbrazilpastandpresentfindingsfromtheglobalburdenofdiseasestudy2015
AT passosvaleriamariadeazeredo burdenofdiabetesandhyperglycemiainbrazilpastandpresentfindingsfromtheglobalburdenofdiseasestudy2015
AT francaelisabethbarboza burdenofdiabetesandhyperglycemiainbrazilpastandpresentfindingsfromtheglobalburdenofdiseasestudy2015
AT marinhofatima burdenofdiabetesandhyperglycemiainbrazilpastandpresentfindingsfromtheglobalburdenofdiseasestudy2015
AT mokdadalih burdenofdiabetesandhyperglycemiainbrazilpastandpresentfindingsfromtheglobalburdenofdiseasestudy2015